TY - JOUR
AU - Hislop, Colin
AB - Varespladib significantly reduces the post-ACS inflammatory response in those with and without diabetes. These responses were greater in diabetic subjects compared to non-diabetic subjects.
TI - Anti-Inflammatory Effects of Varespladib Methyl in Diabetic Patients with Acute Coronary Syndrome
JO - Cardiovascular Drugs and Therapy
DO - 10.1007/s10557-011-6344-2
DA - 2011-10-12
UR - https://www.deepdyve.com/lp/springer-journals/anti-inflammatory-effects-of-varespladib-methyl-in-diabetic-patients-nb2kbxd1SH
SP - 539
EP - 544
VL - 25
IS - 6
DP - DeepDyve
ER -